Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Dermatology|March 20, 2023
Treatment for taxane-resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese casesTaku Fujimura, Takeo Maekawa, Hiroshi Kato, et al.
Oncology Letters|September 12, 2012
Development of hepatocellular carcinoma in patients with chronic hepatitis C more than 10 years after sustained virological response to interferon therapyKeiichiro Nojiri, Kazushi Sugimoto, Katsuya Shiraki, et al.
Radiology Case Reports|July 25, 2026
Squamous cell carcinoma arising from an epidermal cyst: A case series of 5 cases and literature reviewTakuma Usuzaki, Sota Oguro, Shin Hitachi, et al.
Oncotarget|October 21, 2017
Phase I study of nivolumab combined with IFN-β for patients with advanced melanomaTaku Fujimura, Takanori Hidaka, Yumi Kambayashi, et al.
Skin Health and Disease|February 8, 2023
Cutaneous angiosarcoma treated with taxane-based chemoradiotherapy: A multicenter study of 90 Japanese casesTaku Fujimura, Sadanori Furudate, Takeo Maekawa, et al.
Acta Dermato-Venereologica|June 7, 2022
Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese CasesYusuke Muto, Yumi Kambayashi, Hiroshi Kato, et al.
The Journal of Dermatology|July 31, 2023
Adverse events associated with postoperative outcomes of adjuvant anti-PD-1 antibody therapy in both acral and non-acral cutaneous melanomas: A multicenter, observational, post hoc analysis studyYusuke Muto, Yumi Kambayashi, Hiroshi Kato, et al.
The Journal of Dermatology|November 12, 2020
Case series of BRAF-mutated advanced melanoma treated with encorafenib plus binimetinib combination therapyTaku Fujimura, Koji Yoshino, Hiroshi Kato, et al.
Experimental Dermatology|November 10, 2023
Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocolTaku Fujimura, Koji Yoshino, Motoki Nakamura, et al.
Cancers|August 10, 2024
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal SubtypesYusuke Muto, Yumi Kambayashi, Hiroshi Kato, et al.
Pageof 17